Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Biomarkers Market Grown from 2024 to 2025?

The market size for biomarkers has experienced rapid expansion in recent years. Competition will heat up, with a predicted rise from $68.77 billion in 2024 to $78.14 billion in 2025, boasting a compound annual growth rate (CAGR) of 13.6%. The significant growth observed in the historic period can be linked to the progress made in genomics and proteomics technologies, the escalating cases of chronic diseases, the growing focus on personalized medicine, the increased need for companion diagnostics, and the widening applicability in drug development.

What Growth Rate Is Anticipated for the Biomarkers Market in the Coming Years?

The future holds promising expansion for the biomarkers market, with a projected surge to $135.14 billion by 2029. This growth represents a compound annual growth rate (CAGR) of 14.7%. The rise is due to an increasing emphasis on early disease discovery and prevention, broadening of the use of biomarkers in the fields of oncology and immunotherapy, growing investments in precision medicine, emergence of liquid biopsy as a non-invasive method for biomarker detection, and the favoured use of biomarkers in drug discovery and creation. The forecast period will also see trends such as the creation of multi-biomarker panels, the emergence of exosome-based biomarkers, adoption of point-of-care biomarker testing, incorporation of real-world data into biomarker research, and the search for microbiome-based biomarkers.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6485&type=smp

Who Are the Leading Companies in the Biomarkers Market?

Major companies operating in the biomarkers market include Enzo Biochem Inc, Bio-Rad Laboratories Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N. V., Adaptive Biotechnologies Corp., Agilent Technologies Inc., Biocrates Life Sciences AG, BioFire Diagnostics LLC, BioReference Laboratories Inc., Bio-Techne Corporation, Cepheid Inc., Eurofins Scientific SE, Exact Sciences Corporation, Foundation Medicine Inc., Genomic Health Inc., GenScript Biotech Corporation, Guardant Health Inc., Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation, Metabolon Inc., Myriad Genetics Inc., Natera Inc., Pacific Biosciences of California Inc., Quest Diagnostics Incorporated, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Veracyte Inc.

What Are the Key Drivers of the Biomarkers Market?

The rise in cardiac illnesses is predicted to boost the growth of the biomarkers market during the forecast period. There has been a tremendous surge in the application of biomarkers for patients suffering from heart diseases in recent years. At present, natriuretic peptides dominate as the most frequently used biomarker, aiding in the diagnosis of heart failure patients. Other biomarkers like circulating biomarkers loaded with high sensitivity C-reactive protein are also employed for heart failure diagnosis. Heart diseases are a prominent cause of mortality among numerous racial and ethnic groups in the United States, thus increasing the demand for biomarkers. For instance, as per a report by the American College of Cardiology, a non-profit medical association from the United States, published in August 2022, it was projected that all four cardiovascular risk factors would undergo an increase from 2025 to 2060 in the region. Diabetes is predicted to show the highest rise in percentage, increasing by 39.3% to touch 55 million people. It is followed by dyslipidemia, which is expected to increase by 27.6% reaching 126 million people, hypertension is expected to surge by 25.1% reaching 162 million, and obesity with an increase of 18.3% will affect 126 million people. The study also noticed significant projected enhancements in cardiovascular disease rates like strokes, projected to grow by 33.8% affecting 15 million people, and heart failure anticipating an increase of 33.4% to affect 13 million people. This is followed by ischemic heart disease (30.7% to reach 29 million) and heart attacks (16.9% to touch 16 million). The escalation in heart diseases and related mortalities is expected to stimulate the growth of the biomarkers market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=6485&type=smp

What Are the Key Market Segments in the Biomarkers Industry?

The biomarkers market covered in this report is segmented –

1) By Technology: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers

2) By Disease: Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases

3) By Type: Biomarker Of Exposure, Biomarker Of Diseases

4) By Audiences: Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies

Subsegments:

1) By Safety Biomarkers: Toxicity Biomarkers, Pharmacokinetic Biomarkers, Adverse Effect Biomarkers

2) By Efficacy Biomarkers: Pharmacodynamic Biomarkers, Disease Progression Biomarkers, Treatment Response Biomarkers

3) By Validation Biomarkers: Analytical Validation Biomarkers, Clinical Validation Biomarkers, Qualification Biomarkers

What Are the Latest Trends in the Biomarkers Market?

Leading companies in the biomarker market are channeling their efforts into the development of innovative solutions, such as fresh biological markers, to spur innovation through cooperative research, technological fusion, and solid clinical validation. A fresh biological marker represents a freshly discovered indicator that mirrors biological activities and aids in detecting or monitoring diseases. It could be a molecule, gene, or cell feature which may have potential consequences for personalized medicine. For example, Genialis, a computational precision medicine corporation based in the US, inaugurated a first-in-class biomarker in September 2024. This first-in-class biomarker boosts the predictive accuracy for patient responses to KRAS inhibitors, facilitating personalized treatment strategies, and enhancing clinical results. Its comprehensive application across various types of cancer promotes efficient pharmaceutical development and optimizes patient selection for targeted treatments.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

What Are the Key Regional Markets in the Biomarkers Industry?

North America was the largest region in the biomarkers market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6485

This Report Delivers Insight On:

1. How big is the biomarkers market, and how is it changing globally?

2. Who are the major companies in the biomarkers market, and how are they performing?

3. What are the key opportunities and risks in the biomarkers market right now?

4. Which products or customer segments are growing the most in the biomarkers market?

5. What factors are helping or slowing down the growth of the biomarkers market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model